Rethinking the Customer Engagement Model in Japan for COVID-19 and Beyond L.E.K. Consulting Read more
Related Practice Life Sciences & Pharma Unlike many other markets in the world, Japan had until very recently been driven by ‘share-of-voice’, with market development and patient share being largely sensitive to sales activity. 01022024160132
Executive Insights Life Sciences & Pharma In Need of an All-Inclusive Trip: Socio-Demographic Diversity in Psychedelic Research November 15, 2024
Video / Webinar Healthcare Services Global Collaboration Opportunities in China's Healthcare Innovation August 7, 2024
Case Study Life Sciences & Pharma Value Story and Cross-Stakeholder Action Plan for Oncology Reimbursement May 8, 2024 A big pharma company wanted to enable change in payer attitudes to increase the acceptance of patient-reported outcomes (PROs) and of endpoints beyond…
Published Articles Marketing & Sales How Can Businesses Survive the ‘Cookie Apocalypse’? April 25, 2024
Published Articles Life Sciences & Pharma A New Generation of Drug Therapies Requires New Business Strategies February 27, 2024